Bill Texts: OR SB764 | 2021 | Regular Session

Bill Title: Relating to agreements that lead to anticompetitive behavior in the market for pharmaceutical drugs.

Sponsorship: Moderate Partisan Bill (Democrat 15-2)

Status: (Failed) 2021-06-26 - In committee upon adjournment. [SB764 Detail]

Bill Drafts

RevisionDateFormatSourceView
Engrossed2021-04-20PDFLinkView
Introduced2021-04-20PDFLinkView
IntroducedNot AvailPDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Oregon SB764

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for Oregon SB764 currently on file.

feedback